TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway

Molecular and Cellular Biology

Volumn 32, Issue 1, 2012, Pages 50-63

  Jin, Wei ^a,b   Chen, Bo bin ^c   Li, Ji yu ^a,b   Zhu, Hua ^d   Huang, Mark ^d   Gu, Sheng mei ^a,b   Wang, Qiao qiao ^a,b   Chen, Jia ying ^a,b   Yu, Sanjian ^a,b   Wu, Jiong ^a,b   Shao, Zhi ming ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE DEACETYLASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE PRODUCT; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ACETYLATION; ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; PROMOTER REGIONS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84863027799     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06152-11     Document Type: Article

References (40)

1. Alvarez-Rodríguez R, Barzi M, Berenguer J, Pons S. 2007. Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc. J. Biol. Chem. 282:37170-37180.
2. Baselga J. 2002. Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing. Ann. Oncol. 13:8-9.
3. Brandt B, Meyer-Staeckling S, Schmidt H, Agelopoulos K, Buerger H. 2006. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response. Clin. Cancer Res. 12:7252-7260.
4. Capdevila J, et al. 2009. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat. Rev. 35:354-363.
5. Chalaux E, et al. 1999. A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett. 457:478-482.
6. Chang XZ, et al. 2008. Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res. Treat. 111:65-78.
7. Clem BF, Clark BJ. 2006. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene. Mol. Endocrinol. 20:100-113.
8. Cowden Dahl KD, et al. 2008. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res. 68:4606-4613.
9. Deb SP, Muñoz RM, Brown DR, Subler MA, Deb S. 1994. Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9:1341-1350.
10. Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. 2009. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin. Cancer Res. 15:2962-2970.
11. Grandis JR, Sok JC. 2004. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol. Ther. 102:37-46.
12. Grossmann C, et al. 2007. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter. Am. J. Physiol. Endocrinol. Metab. 292:E1790-1800.
13. Hassig CA, et al. 1998. A role for histone deacetylase activity in HDAC1- mediated transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 95:3519-3524.
14. Hirota T, et al. 2010. Transcriptional repressor TIEG1 regulates Bmal1 gene through GC box and controls circadian clockwork. Genes Cells 15:111-121.
15. Huang Y, Wang S, Kelly T. 2004. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 64:2712-2716.
16. Hudson LG, Thompson KL, Xu J, Gill GL. 1990. Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U. S. A. 87:7536-7540.
17. Jin W, et al. 2007. TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade. FEBS Lett. 581:3826-3832.
18. Johnsen SA, Subramaniam M, Janknecht R, Spelsberg TC. 2002. TGFβ inducible early gene enhances TGFβ/Smad-dependent transcriptional responses. Oncogene 21:5783-5790.
19. Lewis TS, Shapiro PS, Ahn NG. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49-139.
20. Liu W, et al. 2003. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin. Cancer Res. 9:1009-1012.
21. Liu W, et al. 2005. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 65:46-53.
22. Liu ZB, et al. 2010. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner. Oncogene 29:2996-3009.
23. Ludes-Meyers JH, et al. 1996. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol. Cell. Biol. 16:6009-6019.
24. Peng SC, Lai YT, Huang HY, Huang HD, Huang YS. 2010. A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons. Nucleic Acids Res. 38:7446-7457.
25. Pitteri SJ, et al. 2010. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users. Cancer Res. 70:8598-8606.
26. Pore N, et al. 2006. EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. Cancer Res. 66:3197-3204.
27. Pusztai L, Lewis CE, Lorenzen J, McGee JO. 1993. Growth factors: regulation of normal and neoplastic growth. J. Pathol. 169:191-201.
28. Reinholz MM, et al. 2004. Differential gene expression of TGFβ inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res. Treat. 86:75-88.
29. Ribeiro A, Bronk SF, Roberts PJ, Urrutia R, Gores GJ. 1999. The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology 30:1490-1497.
30. Subramaniam M, et al. 1995. Identification of a novel TGF-betaregulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 23:4907-4912.
31. Subramaniam M, et al. 2010. TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem. Biophys. Res. Commun. 392:72-76.
32. Tachibana I, et al. 1997. Overexpression of the TGFβ-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J. Clin. Invest. 99:2365-2374.
33. Tau KR, et al. 1998. Estrogen regulation of a transforming growth factorbeta inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts. Endocrinology 139:1346-1353.
34. Toulany M, Baumann M, Rodemann HP. 2007. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Mol. Cancer Res. 5:863-872.
35. van Diest PJ, van der Groep P, van der Wall E. 2006. EGFR expression predicts BRCA1 status in patients with breast cancer. Clin. Cancer Res. 12:670.
36. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489-501.
37. Zhang H, et al. 2007. ErbB receptors: from oncogenes to targeted cancer therapies. J. Clin. Invest. 117:2051-2058.
38. Zhang JS, et al. 2001. A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol. Cell. Biol. 21:5041-5049.
39. Zheleznova NN, Wilson PD, Staruschenko A. 16 October 2010. Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells. Biochim. Biophys. Acta 1812:1301-1313. [Epub ahead of print.]
40. Zheng ZS, Polakowska R, Johnson A, Goldsmith LA. 1992. Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ. 3:225-232.